Related Experiment Video
Updated: Jul 17, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Machine learning and multi-omics integration: advancing cardiovascular translational research and clinical practice
Mingzhi Lin1, Jiuqi Guo1, Zhilin Gu1
1Department of Cardiology, The First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, 110001, People's Republic of China.
Artificial intelligence (AI) and multi-omics data integration are revolutionizing cardiovascular disease research. These approaches offer new insights into disease mechanisms and clinical applications.
Area of Science:
- Biomedical research
- Cardiovascular medicine
- Computational biology
Background:
- Cardiovascular diseases (CVDs) represent a growing global health challenge.
- Multi-omics approaches provide molecular insights into complex physiological and pathological changes in CVDs.
- Managing and interpreting large-scale omics data is a significant hurdle in biomedical research.
Purpose of the Study:
- To review methods for integrating artificial intelligence (AI), particularly machine learning, with omics data in cardiovascular research.
- To summarize AI models that utilize multi-omics data for exploring CVD mechanisms and clinical practice.
- To highlight AI's role in extracting molecular information to address knowledge gaps in cardiovascular diseases.
Main Methods:
- Review of AI and machine learning methodologies applied to omics data.
- Analysis of representative AI models in cardiovascular disease studies.
- Discussion of data integration strategies for multi-omics datasets.
Main Results:
- AI integrated with multi-omics data shows promise in cardiovascular studies.
- AI effectively extracts potential molecular information, addressing current knowledge gaps.
- AI facilitates exploration of cardiovascular diseases from underlying mechanisms to clinical practice.
Conclusions:
- AI and omics integration offers powerful tools for advancing cardiovascular disease research.
- Challenges and opportunities exist in translating these integrated approaches into routine clinical practice.
- Future AI models are anticipated for broader applications in cardiovascular medicine.
More Related Videos
09:47Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
Genomics
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...